Research Review Committee

The purpose of the Reverse Rett Research Review Committee is to ensure that UK research we fund meets the highest scientific and ethical standards. After a proposal has been through external peer review, the Research Advisory Board reviews the proposal and external peer reviews, as well as any subsequent exchange between applicants and external peer reviewers


After individual and group review, the Committee then provides cohesive feedback to the Board of Trustees of Reverse Rett. Their main role is to ensure that any work they recommend for funding meets AMRC research standards and aligns with the Reverse Rett Research Strategy.

The Reverse Rett Research Advisory Board comprises of professionals, including scientists, researchers and independent industry experts as well as patient voice representatives.

Reverse Rett Research Advisory Board

David Greatrex Ph.D.  Chair

Dr Ben Lashbrooke, Patient Voice

John H. Sharpe, Chairman Reverse Rett Non-voting member    

Dr Jay Shetty, Consultant Paediatric Neurologist, Royal Hospital for Children Edinburgh & Edinburgh University

Jatinder Singh, Ph.D. Independent Scientific Advisor

Joanna Tomlin, Patient Voice

Mark Walls, Patient Voice

Mrs Louise Wainwright, Animal Welfare Officer

Deputy Bioscience Support Facility Manager, Nottingham Trent University

Independent Drug Development and Regulatory Affairs Consultant
M Regulatory Affairs Ltd